218 related articles for article (PubMed ID: 29356609)
1. Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.
Clarke MA; Fetterman B; Cheung LC; Wentzensen N; Gage JC; Katki HA; Befano B; Demarco M; Schussler J; Kinney WK; Raine-Bennett TR; Lorey TS; Poitras NE; Castle PE; Schiffman M
J Clin Oncol; 2018 Apr; 36(12):1184-1191. PubMed ID: 29356609
[TBL] [Abstract][Full Text] [Related]
2. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
Befano B; Wentzensen N; Lorey T; Poitras N; Cheung LC; Schiffman M; Clarke MA; Cohen C; Kinney W; Locke A; Castle PE
Gynecol Oncol; 2024 May; 184():89-95. PubMed ID: 38301311
[TBL] [Abstract][Full Text] [Related]
3. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
Silver MI; Schiffman M; Fetterman B; Poitras NE; Gage JC; Wentzensen N; Lorey T; Kinney WK; Castle PE
Cancer; 2016 Dec; 122(23):3682-3686. PubMed ID: 27657992
[TBL] [Abstract][Full Text] [Related]
4. Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.
Landy R; Schiffman M; Sasieni PD; Cheung LC; Katki HA; Rydzak G; Wentzensen N; Poitras NE; Lorey T; Kinney WK; Castle PE
Int J Cancer; 2020 Feb; 146(3):617-626. PubMed ID: 30861114
[TBL] [Abstract][Full Text] [Related]
5. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
6. The role of body mass index in incidence and persistence of cervical human papillomavirus infection.
Urbute A; Thomsen LT; Belmonte F; Kesmodel US; Frederiksen K; Kjaer SK
Ann Epidemiol; 2020 Sep; 49():36-41. PubMed ID: 32711054
[TBL] [Abstract][Full Text] [Related]
7. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.
Gage JC; Schiffman M; Katki HA; Castle PE; Fetterman B; Wentzensen N; Poitras NE; Lorey T; Cheung LC; Kinney WK
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25038467
[TBL] [Abstract][Full Text] [Related]
8. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
9. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
10. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
11. Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.
Saraiya M; Cheung LC; Soman A; Mix J; Kenney K; Chen X; Perkins RB; Schiffman M; Wentzensen N; Miller J
Am J Obstet Gynecol; 2021 Apr; 224(4):366.e1-366.e32. PubMed ID: 33035473
[TBL] [Abstract][Full Text] [Related]
12. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
Hammer A; Demarco M; Campos N; Befano B; Gravitt PE; Cheung L; Lorey TS; Poitras N; Kinney W; Wentzensen N; Castle PE; Schiffman M
Int J Cancer; 2020 Sep; 147(6):1612-1620. PubMed ID: 32141607
[TBL] [Abstract][Full Text] [Related]
13. Variable risk of cervical precancer and cancer after a human papillomavirus-positive test.
Castle PE; Fetterman B; Poitras N; Lorey T; Shaber R; Schiffman M; Demuth F; Kinney W
Obstet Gynecol; 2011 Mar; 117(3):650-656. PubMed ID: 21343769
[TBL] [Abstract][Full Text] [Related]
14. Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention.
Pinheiro M; Gage JC; Clifford GM; Demarco M; Cheung LC; Chen Z; Yeager M; Cullen M; Boland JF; Chen X; Raine-Bennett T; Steinberg M; Bass S; Befano B; Xiao Y; Tenet V; Walker J; Zuna R; Poitras NE; Gold MA; Dunn T; Yu K; Zhu B; Burdett L; Turan S; Lorey T; Castle PE; Wentzensen N; Burk RD; Schiffman M; Mirabello L
Int J Cancer; 2020 Nov; 147(10):2677-2686. PubMed ID: 32363580
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
16. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
17. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
18. Why does cervical cancer occur in a state-of-the-art screening program?
Castle PE; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Schiffman M
Gynecol Oncol; 2017 Sep; 146(3):546-553. PubMed ID: 28606721
[TBL] [Abstract][Full Text] [Related]
19. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
Castle PE; RodrÃguez AC; Burk RD; Herrero R; Wacholder S; Alfaro M; Morales J; Guillen D; Sherman ME; Solomon D; Schiffman M;
BMJ; 2009 Jul; 339():b2569. PubMed ID: 19638649
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.
Wentzensen N; Walker J; Smith K; Gold MA; Zuna R; Massad LS; Liu A; Silver MI; Dunn ST; Schiffman M
Am J Obstet Gynecol; 2018 Jun; 218(6):604.e1-604.e8. PubMed ID: 29462629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
